Orange Book product · Brand (NDA)
KYXATA
CARBOPLATIN
At a glance
Aug 08, 2025
Approved
Brand (NDA)
Application
Not listed
TE code
1
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Aug 08, 2025
11 mo ago
Today
Patent 12427104 expires
Listed drug product patent expiration.
Apr 01, 2045
in 19 yr 1 mo
Pharmaceutical detail
Active ingredient
CARBOPLATIN
Strength
20MG/2ML (10MG/ML)
Dosage form
SOLUTION
Route
INTRAVENOUS
TE code
Not listed
Application
NDA 219921
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2003PARAPLATINBrand (NDA)
NDA 020452 · CORDENPHARMA
- 1989PARAPLATINBrand (NDA)
NDA 019880 · CORDEN PHARMA
- 2026CARBOPLATINGeneric (ANDA)
ANDA 219999 · QILU PHARM HAINAN
- 2020CARBOPLATINGeneric (ANDA)
ANDA 206775 · ACCORD HLTHCARE
- 2017CARBOPLATINGeneric (ANDA)
ANDA 208487 · INGENUS PHARMS LLC
- 2017CARBOPLATINGeneric (ANDA)
ANDA 207324 · GLAND
- 2016CARBOPLATINGeneric (ANDA)
ANDA 205487 · EUGIA PHARMA
- 2012CARBOPLATINGeneric (ANDA)
ANDA 091510 · NATCO PHARMA USA
- 2012CARBOPLATINGeneric (ANDA)
ANDA 078732 · ACTAVIS TOTOWA
- 2011CARBOPLATINGeneric (ANDA)
ANDA 091478 · PHARMOBEDIENT
- 2011CARBOPLATINGeneric (ANDA)
ANDA 091063 · PHARMOBEDIENT
- 2010CARBOPLATINGeneric (ANDA)
ANDA 091268 · EPIC PHARMA LLC
Listed patents (1)
| Patent | Expires | In | Type |
|---|---|---|---|
| 12427104 | Apr 01, 2045 | in 19 yr 1 mo | Product |

